封面
市场调查报告书
商品编码
1741433

全球气候适应性和永续卫生系统市场(按组件、技术、最终用户和地区划分)

Climate Resilient and Sustainable Health Systems Market, By Component, By Technology, By End-User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球气候适应性和永续医疗保健系统市场规模预计在 2025 年达到 107.1 亿美元,预计到 2032 年将达到 245.8 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 12.6%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 107.1亿美元
效能数据 2020-2024 预测期 2025-2032
预测期:2025-2032年复合年增长率: 12.60% 2032年价值预测 245.8亿美元

具有气候韧性和永续的卫生系统对于应对气候变迁带来的挑战以及保障世界各地社区的福祉至关重要。随着气候变迁对人口健康的影响日益加深,对具有韧性和永续的卫生保健系统的需求比以往任何时候都更加迫切。

本报告旨在对全球气候适应型和永续医疗保健系统市场进行深入分析。报告分析了2025年至2032年的市场规模(估值)及其复合年增长率(以2024年为基准年)。报告深入探讨了各个细分领域的潜在商机,并说明了该市场极具吸引力的投资提案。

市场动态:

气候适应性和永续医疗保健系统市场受多种因素驱动。首先,人们日益意识到气候变迁对健康的影响,促使政府和医疗保健组织优先考虑气候适应性和永续性。这导致对能够减少医疗保健碳排放并提高医疗保健系统适应能力的技术和技术的投资增加。

然而,市场也面临许多挑战:有限的财政资源和基础设施阻碍了医疗保健系统采用适应气候变迁和永续的解决方案,尤其是在发展中地区,缺乏评估和应对医疗保健气候风险的标准化框架和指南。

儘管如此,这个市场仍充满机会。将太阳能和地热等可再生能源融入医疗设施,不仅可以减少碳排放,还能从长远来看节省成本。远端医疗和数位医疗解决方案的创新也透过减少对实体基础设施的需求,为建立气候适应型和永续的医疗保健系统创造了机会。

本研究的主要特点

  • 以 2024 年为基准年,详细分析预测期间的全球市场规模及复合年增长率。
  • 发掘各领域的潜在商机和市场有吸引力的投资提案矩阵。
  • 关于市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
  • 包括全球气候适应性和永续卫生系统市场的主要企业简介、公司组合、财务表现、主要亮点和策略。
  • 涵盖的主要企业包括江森自控、霍尼韦尔、施耐德电气、西门子医疗、飞利浦、葛兰素史克、艾伯维、辉瑞、默克公司和诺华。
  • 帮助负责人和经营团队就未来产品发布、市场扩张和行销策略做出决策的见解。
  • 针对产业内的各个相关人员,如投资者、供应商、产品製造商、经销商、新参与企业和财务分析师。
  • 透过分析全球气候永续医疗保健系统市场中使用的各种策略矩阵,为相关人员提供决策便利。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
  • 极端天气事件发生频率和严重性增加
  • 灾难准备和业务永续营运的重要性日益增加
  • 政策措施和政府支持
  • 注重减少温室气体排放
    • 限制因素
  • 预算限制
  • 技术复杂性
    • 机会
  • 气候智慧营运的数据分析与人工智慧
  • 气候风险评估与预测平台
  • 永续医疗技术
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

4. 气候适应性与永续医疗保健系统市场:COVID-19 疫情的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 2020 年至 2032 年气候适应性与永续卫生系统市场(按组成部分)

  • 产品
  • 服务
  • 实施服务
  • 培训服务
  • 支援和维护服务
  • 咨询服务
  • 整合服务

6. 2020 年至 2032 年气候适应性与永续卫生系统市场(按技术划分)

  • 电化学感测器
  • 非色散红外线(NDIR)感测器
  • 金属氧化物半导体(MOS)感测器

7. 2020 年至 2032 年气候适应性与永续卫生系统市场(按最终用户划分)

  • 製药公司
  • 生技公司
  • 医院

8. 2020 年至 2032 年各地区气候适应性与永续卫生系统市场

  • 北美洲
      • 美国
      • 加拿大
  • 欧洲
      • 英国
      • 德国
      • 法国
      • 义大利
      • 西班牙
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳洲
      • 韩国
      • ASEAN
      • 其他亚太地区
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 中东
      • 海湾合作委员会国家
      • 以色列
      • 其他中东地区
  • 非洲
  • 南非
  • 中部非洲
  • 北非

第九章 竞争态势

  • Johnson Controls
  • Honeywell
  • Schneider Electric
  • Siemens Healthineers
  • Philips
  • GSK
  • AbbVie
  • Pfizer
  • Merck & Co.
  • Novartis

第 10 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6236

Climate Resilient and Sustainable Health Systems Market is estimated to be valued at USD 10.71 Bn in 2025 and is expected to reach USD 24.58 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 10.71 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 12.60% 2032 Value Projection: USD 24.58 Bn

Climate Resilient and Sustainable Health Systems are crucial for addressing the challenges that arise from climate change and ensuring the well-being of communities worldwide. With the increasing impact of climate change on human health, the need for resilient and sustainable healthcare systems has become more pressing than ever.

This report aims to provide an in-depth analysis of the global Climate Resilient and Sustainable Health Systems market. It examines the market size, estimated to reach US$ Million, and the compound annual growth rate for the forecast period of 2025-2032, with 2024 as the base year. The report delves into potential revenue opportunities across different segments and explains attractive investment propositions for this market.

Market Dynamics:

The Climate Resilient and Sustainable Health Systems market is driven by several factors. Firstly, the growing awareness of the impacts of climate change on health is pushing governments and healthcare organizations to prioritize climate resilience and sustainability. This is leading to increased investments in technologies and practices that reduce healthcare's carbon footprint and enhance the adaptive capacity of health systems.

However, there are also challenges restraining the market. Limited financial resources and infrastructure hinder the implementation of climate resilient and sustainable solutions in healthcare systems, particularly in developing regions. Additionally, the lack of standardized frameworks and guidelines for assessing and addressing climate risks in healthcare poses a barrier.

Nevertheless, there are ample opportunities in this market. The integration of renewable energy sources, such as solar power and geothermal energy, into healthcare facilities not only reduces carbon emissions but also offers cost savings in the long run. Innovations in telehealth and digital health solutions are also creating opportunities for climate resilient and sustainable healthcare systems by reducing the need for physical infrastructure.

Key Features of the Study:

  • In-depth analysis of the global market size and compound annual growth rate for the forecast period, with 2024 as the base year.
  • Elucidation of potential revenue opportunities across different segments and attractive investment proposition matrices for the market.
  • Key insights into market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • Profiles of key players in the global Climate Resilient and Sustainable Health Systems market, highlighting their company portfolio, financial performance, key highlights, and strategies.
  • Coverage of key companies such as Johnson Controls, Honeywell, Schneider Electric, Siemens Healthineers, Philips, GSK, AbbVie, Pfizer, Merck & Co., and Novartis.
  • Insights to aid decision-making for future product launches, market expansion, and marketing tactics by marketers and management authorities.
  • Catering to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Ease in decision-making for stakeholders through various strategy matrices used in analyzing the global Climate Resilient and Sustainable Health Systems market.

Climate Resilient and Sustainable Health Systems Market Segmentation

  • By Component
    • Solutions
    • Energy Efficiency Systems
    • Renewable Energy Systems
    • Water Conservation Systems
    • Resilient IT Infrastructure
    • Others
    • Services
    • Implementation Services
    • Training Services
    • Support & Maintenance Services
    • Consulting Services
    • Integration Services
  • By End User
    • Healthcare Providers
    • Hospitals
    • Ambulatory Care Centers
    • Diagnostic Centers
    • Others
    • Healthcare Payers
    • Private Payers
    • Public Payers
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles
    • Johnson Controls
    • Honeywell
    • Schneider Electric
    • Siemens Healthineers
    • Philips
    • GSK
    • AbbVie
    • Pfizer
    • Merck & Co.
    • Novartis

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Climate Resilient and Sustainable Health Systems, By Component
    • Market Climate Resilient and Sustainable Health Systems, By Technology
    • Market Climate Resilient and Sustainable Health Systems, By End User
    • Market Climate Resilient and Sustainable Health Systems, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing frequency and severity of extreme weather events
  • Rising emphasis on disaster preparedness and business continuity
  • Policy measures and government support
  • Focus on reducing greenhouse gas emissions
    • Restraints
  • Budget constraints
  • Technical complexity
    • Opportunities
  • Data analytics and AI for climate-smart operations
  • Climate risk assessment and forecasting platforms
  • Sustainable medical technology
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Climate Resilient and Sustainable Health Systems Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Climate Resilient and Sustainable Health Systems Market , By Component, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Product
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Implementation Services
  • Training Services
  • Support & Maintenance Services
  • Consulting Services
  • Integration Services

6. Climate Resilient and Sustainable Health Systems Market , By Technology, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Electrochemical sensors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Non-Dispersive Infrared (NDIR) Sensors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Metal Oxide Semiconductor (MOS) Sensors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Climate Resilient and Sustainable Health Systems Market , By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis,
    • Segment Trends
  • Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
  • Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)

8. Climate Resilient and Sustainable Health Systems Market , By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Region/, 2020-2032,(US$ Bn)
  • South Africa
  • Central Africa
  • North Africa

9. Competitive Landscape

  • Johnson Controls
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Honeywell
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Schneider Electric
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Philips
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • GSK
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • AbbVie
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Pfizer
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck & Co.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novartis
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us